Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) EBIT (2021 - 2025)

Historic EBIT for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to -$57.4 million.

  • Core Scientific's EBIT fell 3931.68% to -$57.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$166.1 million, marking a year-over-year decrease of 77732.96%. This contributed to the annual value of -$19.2 million for FY2024, which is 31421.72% down from last year.
  • Core Scientific's EBIT amounted to -$57.4 million in Q3 2025, which was down 3931.68% from -$26.3 million recorded in Q2 2025.
  • Core Scientific's 5-year EBIT high stood at $102.2 million for Q4 2021, and its period low was -$1.0 billion during Q2 2022.
  • For the 5-year period, Core Scientific's EBIT averaged around -$111.3 million, with its median value being -$12.0 million (2023).
  • Its EBIT has fluctuated over the past 5 years, first tumbled by 848992.47% in 2022, then soared by 62647.99% in 2024.
  • Core Scientific's EBIT (Quarter) stood at $102.2 million in 2021, then plummeted by 722.64% to -$636.1 million in 2022, then soared by 100.62% to $3.9 million in 2023, then crashed by 1111.26% to -$39.8 million in 2024, then crashed by 44.35% to -$57.4 million in 2025.
  • Its EBIT stands at -$57.4 million for Q3 2025, versus -$26.3 million for Q2 2025 and -$42.6 million for Q1 2025.